Evaluation of CRISPR/Cas9 exon‐skipping vector for choroideremia using human induced pluripotent stem cell‐derived RPE is a research paper published in The Journal of Gene Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Japan Society for the Promotion of Science
Grant: 20K09823
National Institutes of Health
Grant: P01‐HL146366
National Institutes of Health
Grant: R01‐HL13535801
National Institutes of Health
Grant: R01‐HL130533
National Institutes of Health
Grant: R01‐EY027789
National Institutes of Health
Grant: R01‐EY028249
NEI NIH HHS
Grant: R01 EY028249
NIH HHS
Grant: R01-EY027789
NIH HHS
Grant: R01-EY028249
NHLBI NIH HHS
Grant: R01 HL130533
NIH HHS
Grant: R01-HL13535801
NEI NIH HHS
Grant: R01 EY027789
NIH HHS
Grant: P01-HL146366
NHLBI NIH HHS
Grant: P01 HL146366
NIH HHS
Grant: R01-HL130533
National Institutes of Health
Grant: 5P01HL146366-04
Combinatorial Regulation of Gene Networks During Cardiac Development and Disease
National Institutes of Health
Grant: 5R01EY028249-05
Therapeutic genome editing to treat Best disease
National Institutes of Health
Grant: 5R01EY027789-05
Transcriptional regulation of BEST1 in retina pigment epithelium.
FWCI
0.16
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals